Obesity is a major contributor to the metabolic syndrome. The mechanisms by which excess adiposity may promote the development of vascular disease remain obscure. Understanding how well-defined alterations in body weight affect inflammation, insulin resistance, and vascular structure and function will provide new insight into the complex pathophysiology of an extremely common disorder. Our proposed SCCOR will utilize a unique Core dedicated to implementing standardized weight loss protocols in obese people with the metabolic syndrome in order to facilitate discovery research in these patients. The Clinical Science Service Core (CSSC, Core Unit A) will help SCCOR investigators: 1) recruit subjects for the research studies that involve human volunteers (Projects 1, 3, 4, 5, and 6), 2) provide effective weight loss therapy for subjects participating in protocols that require subjects to lose weight (Projects 3, 4, 5, and 6), and 3) obtain appropriate blood and tissue samples for basic science investigators conducting studies in human subjects. The CSSC will be comprised of a Weight Management Unit (WMU), a Subject Recruitment Unit (SRU), and Sample Acquisition Unit (SAU), supervised by the same staff to ensure smooth interaction among the units and reduce overall administrative costs. The WMU will use a multidisciplinary approach to achieve weight loss in study subjects. It is estimated that a total of 65 subjects will be enrolled in weight loss therapy for Projects 3, 5, and 6 and that an additional 40 subjects will enroll in weight loss therapy for Project 4. The SRU will assist investigators in identifying and recruiting appropriate study subjects for Projects 1, 3, 4, 5, and 6, and will maintain a computerized database of research volunteers. The SAU will obtain blood and muscle tissue samples from obese subjects before and after weight loss for Projects 3, 4, and 5. This Core has the potential to transform the care of people with the metabolic syndrome by establishing a framework for linking basic research discoveries in vascular disease to potentially beneficial effects of weight loss in humans.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL083762-05
Application #
8072196
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
2013-04-30
Budget Start
2010-05-01
Budget End
2013-04-30
Support Year
5
Fiscal Year
2010
Total Cost
$72,561
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Jamis-Dow, Carlos A; Barbier, George H; Watkins, Mary P et al. (2014) Bicuspid Pulmonic Valve and Pulmonary Artery Aneurysm. Cardiol Res 5:83-84
Airhart, Nathan; Brownstein, Bernard H; Cobb, J Perren et al. (2014) Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin. J Vasc Surg 60:1033-41; discussion 1041-2
Thatcher, Sean E; Zhang, Xuan; Howatt, Deborah A et al. (2014) Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 34:2617-23
Jin, Jianping; Arif, Batool; Garcia-Fernandez, Francisca et al. (2012) Novel mechanism of aortic aneurysm development in mice associated with smoking and leukocytes. Arterioscler Thromb Vasc Biol 32:2901-9
Razani, Babak; Feng, Chu; Coleman, Trey et al. (2012) Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 15:534-44
Jiang, Xuntian; Sidhu, Rohini; Porter, Forbes D et al. (2011) A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res 52:1435-45
Wei, Xiaochao; Schneider, Jochen G; Shenouda, Sherene M et al. (2011) De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. J Biol Chem 286:2933-45
Razani, Babak; Zhang, Haixia; Schulze, P Christian et al. (2011) Fatty acid synthase modulates homeostatic responses to myocardial stress. J Biol Chem 286:30949-61
Porter, Forbes D; Scherrer, David E; Lanier, Michael H et al. (2010) Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med 2:56ra81
Marquart, Tyler J; Allen, Ryan M; Ory, Daniel S et al. (2010) miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A 107:12228-32

Showing the most recent 10 out of 28 publications